Women s Ischemia Trial to Reduce Events in Non-Obstructive CAD
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Coronary Artery Disease
-
Age: Between 18 years - 100 years
-
Gender: Female
-
Other Inclusion Criteria:
- Signs and symptoms of suspected ischemia prompting referral for further evaluation by cardiac catheterization, or coronary angiogram or coronary CT angiogram within 5 years from consent
- Non-obstructive CAD defined as 0 to 49% diameter narrowing of a major epicardial coronary artery
- Willing to provide written informed consent
You may not be eligible for this study if the following are true:
-
- History of noncompliance to medical therapy or follow-up
- History of non-ischemic dilated or hypertrophic cardiomyopathy
- Documented acute coronary syndrome within previous 30 days
- Left ventricular ejection fraction (LVEF) less than 40%, NYHA class III-IV, or hospitalization for heart failure with reduced ejection fraction (HFrEF) within 180 days
- Stroke within previous 180 days or intracranial hemorrhage at any time
- End-stage renal disease, on dialysis, or estimated glomerular filtration rate (eGFR) less than 30 ml/min.
- Severe valvular disease or likely to require surgery/TVAR within 3 yrs
- Life expectancy less than 3 years due to non-cardiovascular comorbidity
- Enrolled in a competing clinical trial.
- Prior intolerance to both an ACE-I and ARB
- If intolerant to a statin unless taking a PCSK9 as a statin replacement by their clinical provider
- Pregnant
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.